Pay in 4 interest-free payments of $5.47 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Triple-hormone-receptor agonist Retatrutide for obesity: Phase 2 trial (48-week study, up to 24% weight loss) American Diabetes Association (2023) ADA Press Release: Novel agent Retatrutide results in substantial weight reduction (83rd Scientific Sessions, Phase 2 data) ADA Meeting News (2023) Phase 2 trial results: benefits of Retatrutide in obesity, type 2 diabetes, NASH (83rd ADA Scientific Sessions coverage) ClinicalTrials.gov Study of Retatrutide (LY3437943) in adults with obesity (NCT04881760
You're injecting inactive compound
They work best alongside a balanced diet and regular movement
Alongside breaking down existing fat, AOD9604 also suppresses fatty acid synthesis, limiting new fat formation
However, the FDA has not yet approved it for weight loss, and long-term research remains limited
Pricing: 10mg listed at $99.99 as of July 2026, the highest standing 10mg price in this comparison, and visible only after logging in for professional pricing 24 batch-numbered certificates published directly on the BPC-157 product page Per-batch purity, sterility, and endotoxin documentation with public links Product pricing gated behind account registration, and purity stated inconsistently 9
US$ 24.12
US$ 20.50
US$ 28.98
US$ 21.33
US$ 29.62
